Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Committee approves submission of public-health testimony supporting LD 104 and LD 1847
Loading...
Summary
Bangor Public Health and Community Services staff provided testimony drafts and the Government Operations Committee approved submitting testimony urging consideration of LD 104 and LD 1847 to address cannabis product safety and youth protections.
The Government Operations Committee on May 5 approved submission of testimony prepared by Bangor Public Health and Community Services in support of two bills, LD 104 and LD 1847, addressing cannabis product safety and protections for youth and medical users.
Jen Gunderman, director of Bangor Public Health and Community Services, presented testimony prepared by Jamie Comstock and summarized key provisions: establishing a maximum THC potency, creating a study group on youth cannabis use, diverting a portion of adult-use cannabis tax revenue to public-health education and safety awareness, and requiring certain edible gummies in blister packaging unless stamped with the universal symbol. Gunderman said Maine is the only state with a medical cannabis program that does not mandate testing for harmful substances and that these measures aim to protect medical users and youth.
The committee recorded no objections to submitting the testimony; Gunderman noted the public hearing has already occurred but written testimony can still be submitted. The committee authorized staff to submit the "ought to pass" testimony on behalf of the city.
